Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis

By afschroeder • August 21, 2025

Trapnell BC, Inoue Y, Bonella F, Wang T, McCarthy C, Arai T, Akasaka K, Mariani F, Mogulkoc N, Song JW, Baba T, Jouneau S, Numakura T, Öcal N, Mihaltan F, Ataya A, Bendstrup E, Campo I, Carey B, Arena R, Robinson B, Fleming R, Wasfi Y, Pratt R; IMPALA-2 Trial Investigators. Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. N Engl J Med. 2025 Aug 21;393(8):764-773. doi: 10.1056/NEJMoa2410542. PMID: 40834301.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Effects of hemodialysis on hemoglobin oxygen affinity and cardiac function

Sharma S, Nguyen KL, Salusky IB, Ganz T, Ix JH. Effects of hemodialysis on hemoglobin oxygen affinity and cardiac function. Clin Kidney J. 2025 Jul[...]

Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk

Cameron SJ, Li XS, Benson TW, Conrad KA, Wang Z, Fleifil S, Maegdefessel L, Mani K, Björck M, Scalise A, Pham M, Shim S, Wanhainen[...]

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel

Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen[...]